bazedoxifene has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolton, JL; Chandrasena, RE; Choi, J; Hemachandra, LP; Michalsen, BT; Patel, H; Piyankarage, SC; Scism, RA; Siklos, MI; Thatcher, GR; Thayer, EN; Wang, S; Wang, Y; Xiong, R | 1 |
| Gordon, IO; Greene, GL; Krausz, TN; Lee, W; Lengyel, E; Leonhardt, P; Mitra, AK; Mui, KL; Penicka, CV; Romero, IL; Zhao, Y | 1 |
2 other study(ies) available for bazedoxifene and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.
Topics: Cell Transformation, Neoplastic; Cells, Cultured; Cytoprotection; Estradiol; Humans; Inactivation, Metabolic; Indoles; Mammary Glands, Human; MCF-7 Cells; Oxidants; Oxidative Stress; Piperidines; Raloxifene Hydrochloride; Reactive Oxygen Species; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Up-Regulation | 2014 |
The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.
Topics: Animals; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Interactions; Estradiol; Estrogen Antagonists; Female; Genetic Predisposition to Disease; Indoles; Mice; Mice, Transgenic; Neoplasm Invasiveness; Ovarian Neoplasms; Ovary; Selective Estrogen Receptor Modulators | 2012 |